Comment on Bloomberg website from a few days ago from GSK Spokesman in phone interview from London:
"Glaxo’s Rea said today that the drugmaker is producing Relenza at “full capacity.” Glaxo is “urgently assessing mechanisms to increase production of Relenza,” the company said in a statement."
Eventually BTA will bank the royalty cheque from this full capacity.
BTA story still has some legs.
Regards
Buffett
PS Suspect full capacity production of Relenza can top $33.2m for a quarter!
Add to My Watchlist
What is My Watchlist?